Original Article
Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets
R. Yazdania,b,c, R. Seifya, M. Ganjalikhani-Hakemia,
, H. Abolhassanib, N. Eskandaria, F. Golsaz-Shirazid, B. Ansaripoure, E. Salehie, G. Azizif, N. Rezaeib,e,g, A. Aghamohammadib,
Corresponding author
Corresponding author
a Department of Immunology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
b Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
c Molecular Immunology Interest Group (MIIG), Universal Scientific Education and Research Network (USERN), Isfahan, Iran
d Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
e Department of Immunology, Tehran University of Medical Sciences, Tehran, Iran
f Department of Laboratory Medicine, Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran
g Network of Immunity in Infection, Autoimmunity and Malignancy (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
Read
9017
Timeswas read the article
2552
Total PDF
6465
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 53 | 15 | 68 |
| 2025 11 | 247 | 127 | 374 |
| 2025 10 | 203 | 158 | 361 |
| 2025 9 | 166 | 142 | 308 |
| 2025 8 | 194 | 157 | 351 |
| 2025 7 | 202 | 82 | 284 |
| 2025 6 | 139 | 81 | 220 |
| 2025 5 | 168 | 71 | 239 |
| 2025 4 | 136 | 86 | 222 |
| 2025 3 | 103 | 46 | 149 |
| 2025 2 | 125 | 37 | 162 |
| 2025 1 | 141 | 32 | 173 |
| 2024 12 | 97 | 43 | 140 |
| 2024 11 | 87 | 39 | 126 |
| 2024 10 | 89 | 32 | 121 |
| 2024 9 | 87 | 25 | 112 |
| 2024 8 | 84 | 20 | 104 |
| 2024 7 | 110 | 16 | 126 |
| 2024 6 | 95 | 32 | 127 |
| 2024 5 | 88 | 19 | 107 |
| 2024 4 | 79 | 30 | 109 |
| 2024 3 | 107 | 26 | 133 |
| 2024 2 | 127 | 15 | 142 |
| 2024 1 | 128 | 44 | 172 |
| 2023 12 | 103 | 13 | 116 |
| 2023 11 | 131 | 28 | 159 |
| 2023 10 | 150 | 35 | 185 |
| 2023 9 | 106 | 35 | 141 |
| 2023 8 | 99 | 17 | 116 |
| 2023 7 | 131 | 35 | 166 |
| 2023 6 | 114 | 17 | 131 |
| 2023 5 | 155 | 23 | 178 |
| 2023 4 | 149 | 22 | 171 |
| 2023 3 | 107 | 12 | 119 |
| 2023 2 | 75 | 21 | 96 |
| 2023 1 | 109 | 20 | 129 |
| 2022 12 | 52 | 19 | 71 |
| 2022 11 | 97 | 16 | 113 |
| 2022 10 | 94 | 19 | 113 |
| 2022 9 | 75 | 24 | 99 |
| 2022 8 | 67 | 45 | 112 |
| 2022 7 | 57 | 22 | 79 |
| 2022 6 | 55 | 32 | 87 |
| 2022 5 | 337 | 18 | 355 |
| 2022 4 | 48 | 20 | 68 |
| 2022 3 | 88 | 32 | 120 |
| 2022 2 | 91 | 22 | 113 |
| 2022 1 | 112 | 36 | 148 |
| 2021 12 | 40 | 33 | 73 |
| 2021 11 | 93 | 25 | 118 |
| 2021 10 | 69 | 40 | 109 |
| 2021 9 | 51 | 43 | 94 |
| 2021 8 | 74 | 22 | 96 |
| 2021 7 | 60 | 29 | 89 |
| 2021 6 | 41 | 15 | 56 |
| 2021 5 | 56 | 19 | 75 |
| 2021 4 | 109 | 23 | 132 |
| 2021 3 | 96 | 36 | 132 |
| 2021 2 | 17 | 27 | 44 |
| 2021 1 | 69 | 19 | 88 |
| 2020 12 | 4 | 10 | 14 |
| 2020 11 | 0 | 10 | 10 |
| 2020 10 | 1 | 9 | 10 |
| 2020 9 | 0 | 2 | 2 |
| 2020 8 | 0 | 8 | 8 |
| 2020 7 | 0 | 15 | 15 |
| 2020 6 | 0 | 11 | 11 |
| 2020 5 | 0 | 21 | 21 |
| 2020 4 | 0 | 14 | 14 |
| 2020 3 | 0 | 4 | 4 |
| 2020 2 | 0 | 16 | 16 |
| 2020 1 | 0 | 13 | 13 |
| 2019 12 | 0 | 16 | 16 |
| 2019 11 | 1 | 16 | 17 |
| 2019 10 | 1 | 12 | 13 |
| 2019 9 | 2 | 14 | 16 |
| 2019 8 | 1 | 22 | 23 |
| 2019 7 | 0 | 6 | 6 |
| 2019 6 | 0 | 2 | 2 |
| 2019 5 | 0 | 22 | 22 |
| 2018 6 | 1 | 0 | 1 |
| 2018 2 | 14 | 9 | 23 |
| 2018 1 | 5 | 8 | 13 |
| 2017 12 | 0 | 1 | 1 |
| 2017 2 | 3 | 1 | 4 |
| 2016 12 | 0 | 1 | 1 |
Show all
